Cite

HARVARD Citation

    Palluzzi, E. et al. (2022). Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance. International journal of gynecological cancer. 32 (9), pp. 1164-1170. [Online]. 
  
Back to record